HSA — authorised 1 February 2013
- Marketing authorisation holder: HYPERION THERAP INC
- Status: likely_approved
HSA authorised Ravicti on 1 February 2013
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. HSA authorised it on 1 February 2013.
HYPERION THERAP INC holds the Singaporean marketing authorisation.